188 related articles for article (PubMed ID: 23833070)
1. A murine model for retinopathy of prematurity identifies endothelial cell proliferation as a potential mechanism for plus disease.
Guaiquil VH; Hewing NJ; Chiang MF; Rosenblatt MI; Chan RV; Blobel CP
Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5294-302. PubMed ID: 23833070
[TBL] [Abstract][Full Text] [Related]
2. Quantification of vascular tortuosity as an early outcome measure in oxygen induced retinopathy (OIR).
Scott A; Powner MB; Fruttiger M
Exp Eye Res; 2014 Mar; 120():55-60. PubMed ID: 24418725
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal Delivery of VEGF-A
Mezu-Ndubuisi OJ; Wang Y; Schoephoerster J; Falero-Perez J; Zaitoun IS; Sheibani N; Gong S
Curr Eye Res; 2019 Mar; 44(3):275-286. PubMed ID: 30383455
[TBL] [Abstract][Full Text] [Related]
4. Structural consequences after intravitreal bevacizumab injection without increasing apoptotic cell death in a retinopathy of prematurity mouse model.
Akkoyun I; Karabay G; Haberal N; Dagdeviren A; Yilmaz G; Oto S; Erkanli L; Akova YA
Acta Ophthalmol; 2012 Sep; 90(6):564-70. PubMed ID: 20698831
[TBL] [Abstract][Full Text] [Related]
5. Avastin treatment reduces retinal neovascularization in a mouse model of retinopathy of prematurity.
Rabinowitz R; Priel A; Rosner M; Pri-Chen S; Spierer A
Curr Eye Res; 2012 Jul; 37(7):624-9. PubMed ID: 22578253
[TBL] [Abstract][Full Text] [Related]
6. Epithelial Membrane Protein 2 (EMP2) Promotes VEGF-Induced Pathological Neovascularization in Murine Oxygen-Induced Retinopathy.
Sun M; Wadehra M; Casero D; Lin MC; Aguirre B; Parikh S; Matynia A; Gordon L; Chu A
Invest Ophthalmol Vis Sci; 2020 Feb; 61(2):3. PubMed ID: 32031575
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous assessment of aberrant retinal vascularization, thickness, and function in an in vivo mouse oxygen-induced retinopathy model.
Mezu-Ndubuisi OJ; Adams T; Taylor LK; Nwaba A; Eickhoff J
Eye (Lond); 2019 Mar; 33(3):363-373. PubMed ID: 30209267
[TBL] [Abstract][Full Text] [Related]
8. Relationship between Pericytes and Endothelial Cells in Retinal Neovascularization: A Histological and Immunofluorescent Study of Retinal Angiogenesis.
Choi SH; Chung M; Park SW; Jeon NL; Kim JH; Yu YS
Korean J Ophthalmol; 2018 Feb; 32(1):70-76. PubMed ID: 29376221
[TBL] [Abstract][Full Text] [Related]
9. Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice.
Kim KL; Suh W
Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3592-3599. PubMed ID: 28715845
[TBL] [Abstract][Full Text] [Related]
10. New quantitative analysis, using high-resolution images, of oxygen-induced retinal neovascularization in mice.
Chikaraishi Y; Shimazawa M; Hara H
Exp Eye Res; 2007 Mar; 84(3):529-36. PubMed ID: 17208227
[TBL] [Abstract][Full Text] [Related]
11. Preliminary study of retinal pathological features in preterm birth pups exposed to an animal model of oxygen-induced retinopathy in mice.
Chu ZJ; Dou GR; Wang YS; Qu XJ; Zhang Y
Graefes Arch Clin Exp Ophthalmol; 2013 Aug; 251(8):1937-43. PubMed ID: 23740517
[TBL] [Abstract][Full Text] [Related]
12. Antiangiogenic effect of betaine on pathologic retinal neovascularization via suppression of reactive oxygen species mediated vascular endothelial growth factor signaling.
Park SW; Jun HO; Kwon E; Yun JW; Kim JH; Park YJ; Kang BC; Kim JH
Vascul Pharmacol; 2017 Mar; 90():19-26. PubMed ID: 27473515
[TBL] [Abstract][Full Text] [Related]
13. The effect of thalidomide on neovascularization in a mouse model of retinopathy of prematurity.
Rabinowitz R; Katz G; Rosner M; Pri-Chen S; Spierer A
Graefes Arch Clin Exp Ophthalmol; 2008 Jun; 246(6):843-8. PubMed ID: 18343940
[TBL] [Abstract][Full Text] [Related]
14. RhoA activation and effect of Rho-kinase inhibitor in the development of retinal neovascularization in a mouse model of oxygen-induced retinopathy.
Fang X; Ueno M; Yamashita T; Ikuno Y
Curr Eye Res; 2011 Nov; 36(11):1028-36. PubMed ID: 21999228
[TBL] [Abstract][Full Text] [Related]
15. Sildenafil attenuates vaso-obliteration and neovascularization in a mouse model of retinopathy of prematurity.
Fawzi AA; Chou JC; Kim GA; Rollins SD; Taylor JM; Farrow KN
Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1493-501. PubMed ID: 24519428
[TBL] [Abstract][Full Text] [Related]
16. Anti-angiogenic effect of KH902 on retinal neovascularization.
Wang F; Bai Y; Yu W; Han N; Huang L; Zhao M; Zhou A; Zhao M; Li X
Graefes Arch Clin Exp Ophthalmol; 2013 Sep; 251(9):2131-9. PubMed ID: 23740520
[TBL] [Abstract][Full Text] [Related]
17. Soluble forms of EphrinB2 and EphB4 reduce retinal neovascularization in a model of proliferative retinopathy.
Zamora DO; Davies MH; Planck SR; Rosenbaum JT; Powers MR
Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2175-82. PubMed ID: 15914639
[TBL] [Abstract][Full Text] [Related]
18. T2-TrpRS inhibits preretinal neovascularization and enhances physiological vascular regrowth in OIR as assessed by a new method of quantification.
Banin E; Dorrell MI; Aguilar E; Ritter MR; Aderman CM; Smith AC; Friedlander J; Friedlander M
Invest Ophthalmol Vis Sci; 2006 May; 47(5):2125-34. PubMed ID: 16639024
[TBL] [Abstract][Full Text] [Related]
19. Phosphomannopentaose sulfate (PI-88) suppresses angiogenesis by downregulating heparanase and vascular endothelial growth factor in an oxygen-induced retinal neovascularization animal model.
Liang XJ; Yuan L; Hu J; Yu HH; Li T; Lin SF; Tang SB
Mol Vis; 2012; 18():1649-57. PubMed ID: 22773903
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of NAD(P)H oxidase reduces apoptosis and avascular retina in an animal model of retinopathy of prematurity.
Saito Y; Geisen P; Uppal A; Hartnett ME
Mol Vis; 2007 Jun; 13():840-53. PubMed ID: 17615545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]